Inventiva (IVA) Times Interest Earned (2020 - 2021)
Inventiva (IVA) recorded quarterly Times Interest Earned of $6.23 in Q2 2021, up 103.13% quarter-over-quarter from -$198.84 in Q1 2021, and down 98.03% on a YoY basis from $316.43 in Q2 2020.
Inventiva (IVA) Times Interest Earned (2020 - 2021) Analysis & Trends
Inventiva's Times Interest Earned history runs 2 years deep, the most recent figure standing at $6.23 for Q2 2021.
- In Q2 2021, Times Interest Earned fell 98.03% year-over-year to $6.23; the TTM figure through Jun 2021 stood at $28.44 (changed N/A YoY), while the FY2025 annual figure was -$4.2, down 282.92% from the prior year.
- Times Interest Earned was $6.23 for Q2 2021 at Inventiva, up from -$198.84 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $523.46 in Q1 2020 to a low of -$1651.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 6.23 |
| Mar 31, 2021 | -198.84 |
| Dec 31, 2020 | -1,651.00 |
| Jun 30, 2020 | 316.43 |
| Mar 31, 2020 | 523.46 |